The product is Chitosan-poly (viny alcohol) (PVA) crosslinked biopolymer, highly absorbent hemostatic dressing , designed to treat chronic wounds by effectively managing exudates, pain relief and scar improvement. When this wound dressing is used on exudating wounds, it sequesters the exudate fluid and damaged cell, infected necrotic tissue and bacteria present in it, thereby trapping them. This leads to well management of drainage and removal of cellular debris from the wound site. The dressings also absorbs blood plasma that leads to the concentration of erythrocytes and platelets in the injured place, thereby promotes coagulation and activation due to charged-based interaction. These dressings also has been proven to safe and biocompatable. as per ISO 10993. we already received test manufacturing license from CDSCO for making samples for testing and evaluation. Prior to clinical studies, we are planning to conduct an in vivo wound healing study in a diabetic wound model. This study is mandatory to mitigate the risks and to gain confidence for performing clinical investigation especially in chronic non-healing wounds like foot ulcer.